Len Blavatnik, 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), bought 769,230 shares at $13.00 ($10.0M) on 2023-06-09, disclosed to the SEC on 2023-06-12.
Open-market purchase of $10.0M DAWN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| VRNA | BUY | 2022-08-17 | $6.3M | — | Filing → |
| DAWN | BUY | 2022-06-21 | $18.0M | — | Filing → |
| WMG | SELL | 2022-01-07 | $696.3M | — | Filing → |